Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2014
05/01/2014WO2014063178A1 Film coating composition
05/01/2014WO2014038593A3 Granulated material for tablet that rapidly disintegrates in mouth
05/01/2014WO2014036314A3 Diagnosis of rheumatoid arthritis (ra) using differentially methylated loci identified in peripheral blood mononuclear cells, t-cells, b-cells and monocytes
05/01/2014WO2014033744A3 A novel pharmaceutical composition of linezolid
05/01/2014WO2014005107A3 Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture
05/01/2014WO2013186793A9 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
05/01/2014WO2013112491A8 Tunable hydrogel materials and methods for preparing the same
05/01/2014WO2013068565A3 Melatonin-based solutions and powders for their preparation
05/01/2014WO2013052167A3 Membrane encapsulated nanoparticles and method of use
05/01/2014WO2012158405A3 Compositions and methods for the treatment of skin diseases
05/01/2014WO2012135246A3 Compositions and methods for inhibiting expression of tmprss6 gene
05/01/2014WO2012135176A3 The use of wnt agents to prevent hypoxic injury
05/01/2014WO2012134590A3 Calcium supplement
05/01/2014US20140121611 Compositions and methods for transdermal delivery of amphetamine
05/01/2014US20140121609 Implantable therapeutic device
05/01/2014US20140121283 Methods of using derivatives of (-)-venlafaxine
05/01/2014US20140121274 Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva
05/01/2014US20140121255 Methods of Treating Psoriasis Using Allantoin
05/01/2014US20140121234 Inhalant propellant-free aerosol formulation
05/01/2014US20140121232 Abuse-deterrent drug formulations
05/01/2014US20140121169 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
05/01/2014US20140121162 Freeze-dried formulations of fgf-18
05/01/2014US20140121161 Repairing bruch's membrane with hydrogels
05/01/2014US20140120178 Multi-Component Encapsulated Reactive Formulations
05/01/2014US20140120169 Device and method for encapsulation of hydrophilic materials
05/01/2014US20140120168 Metastable silver nanoparticle composites
05/01/2014US20140120167 Multifunctional chemo- and mechanical therapeutics
05/01/2014US20140120166 Composition of entacopone
05/01/2014US20140120165 Corticosteroid particles and method of production
05/01/2014US20140120164 Polymer release system
05/01/2014US20140120163 Coated tablet formulation and method
05/01/2014US20140120161 Vector for oral administration
05/01/2014US20140120156 Compositions and methods for exosome targeted expression
05/01/2014US20140120153 Methods and Compositions for Improved Delivery Devices
05/01/2014US20140120151 Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use
05/01/2014US20140120150 Dissolvable Strip for Treatment of Oral Thermal Burns
05/01/2014US20140120147 Isoxazoline derivatives as pesticides
05/01/2014US20140120141 Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
05/01/2014US20140120139 Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
05/01/2014US20140120138 Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvants
05/01/2014US20140120078 Fragmented polymeric compositions and methods for their use
05/01/2014US20140116435 Inhaler for the administration of an anticholinergic
04/2014
04/30/2014EP2725103A2 Methods and compositions for treating prostate cancer
04/30/2014EP2725053A1 Branched amphipathic block polymer and molecular aggregate and drug delivery system using same
04/30/2014EP2725033A1 Method for producing protein preparation
04/30/2014EP2724775A1 Method for the production of micro-, sub-micro- and nano-capsules, based on milk serum proteins
04/30/2014EP2724719A1 Temporary embolization using inverse thermosensitive polymers
04/30/2014EP2724718A1 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same
04/30/2014EP2724717A1 Surface treatment method for magnetic particles, magnetic composite prepared thereby, and magnetic composite for labeling target materials
04/30/2014EP2724716A1 Phosphodiesterase inhibitors applied via the transvaginal route for the treatment of infertility
04/30/2014EP2724704A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
04/30/2014EP2724670A1 Detecting altered pH levels of rumens
04/30/2014EP2723792A1 Bioresorbable microparticles
04/30/2014EP2723439A1 Applicator system for applying a viscous liquid to the human skin
04/30/2014EP2723394A1 Formulations of fluorinated stilbene suitable for pet imaging
04/30/2014EP2723388A1 Controlled release system
04/30/2014EP2723387A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use
04/30/2014EP2723386A1 An aqueous composition comprising a biological antigen and an acrylic acid polymer
04/30/2014EP2723385A1 Film-forming composition, and use thereof for treating herpes
04/30/2014EP2723341A1 Fast dissolving azaperone granulate formulation
04/30/2014EP2723331A2 Non-leaching antimicrobial wound dressing
04/30/2014EP2723327A1 Biocompatible film with variable cross-sectional properties
04/30/2014EP2723326A1 Topical film-forming composition, and use thereof for treating mycoses
04/30/2014EP2723325A1 Novel formulations and methods for treating dermatological disorders or diseases
04/30/2014EP2723324A1 Compositions and methods for the treatment of cancer
04/30/2014EP2723323A1 Lyophilization of synthetic liposomal pulmonary surfactant
04/30/2014EP2723322A1 Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
04/30/2014EP2723321A1 Toroidal pharmaceutical formulations
04/30/2014EP2723320A1 Liquid pharmaceutical composition comprising nitisinone
04/30/2014EP2723319A1 Composition comprising an onion extract and liposomes
04/30/2014EP2723318A2 Drug delivery formulations
04/30/2014EP2723317A1 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
04/30/2014CN203564564U Double-effect energy-saving and cooling device for powdered material
04/30/2014CN103764272A Systems and methods for shell encapsulation
04/30/2014CN103764270A Encapsulated polar materials and methods of preparation
04/30/2014CN103764176A Compressed gas aerosols with enhanced intensity and longevity of actives
04/30/2014CN103764172A Controlled release system
04/30/2014CN103764168A Aqueous ophthalmic composition
04/30/2014CN103764154A Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
04/30/2014CN103764146A Nicorandil-containing pharmaceutical composition
04/30/2014CN103764135A Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride
04/30/2014CN103764129A Transdermal patch disposal system
04/30/2014CN103764128A Novel formulations and methods for treating dermatological disorders or diseases
04/30/2014CN103764127A Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same
04/30/2014CN103764126A Pharmaceutical composition and solid galenic form having a high dronedarone content, and method for preparing same
04/30/2014CN103764125A Multi-layered release formulation
04/30/2014CN103764124A Coating composition comprising a cellulose ether and starch
04/30/2014CN103764123A Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for same
04/30/2014CN103764122A Liposome comprising at least one cholesterol derivative
04/30/2014CN103764121A Liposomes having useful N:P ratio for delivery of RNA molecules
04/30/2014CN103764120A Macrogol 15 hydroxystearate formulations
04/30/2014CN103764119A Intranasal pharmaceutical dosage forms comprising naloxone
04/30/2014CN103764118A Topical ophthalmological pharmaceutical composition containing sorafenib
04/30/2014CN103764117A Freeze dried drug nanosuspensions
04/30/2014CN103764115A Antioxidant topical compositions
04/30/2014CN103763939A Method for preparing an aromatic composition including a compound containing two solids having organoleptic properties
04/30/2014CN103755968A Ternary molecular brush polymer with double responsivenesses to pH and temperature and nano capsule prepared from ternary molecular brush polymer
04/30/2014CN103755728A Cefazolin derivative and preparation method thereof as well as oral antibiotic preparation
04/30/2014CN103755694A Treatment method of azilsartan crude drug
04/30/2014CN103755670A Potassium sodium dehydroandroan drographolide succinate compound and pharmaceutical composition thereof
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 2991